H.J. Herrema PhD

PhD H.J. Herrema

Position

Assistant Professor

Main activities

Research

Specialisation

Diabetes, Gut microbiome

Focus of research

Translational and integrative research on development of cardiometabolic diseases.

Special interest in the gut microbiome, particularly bacteriophages.

Amsterdam UMC Research Institutes

AMC departments

Wortelboer Koen, Nieuwdorp Max, Herrema Hilde Fecal microbiota transplantation beyond Clostridioides difficile infections EBioMedicine 2019;44:716-729 [PubMed]
van Bommel E. J. M., Herrema H., Davids M., Kramer M. H. H., Nieuwdorp M., van Raalte D. H. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes Diabetes & metabolism 2020;46 (2):164-168 [PubMed]
Herrema Hilde, Zhou Yingjiang, Zhang Dongyan, Lee Justin, Salazar Hernandez Mario Andres, Shulman Gerald I, Ozcan Umut XBP1s Is an Anti-lipogenic Protein Journal of biological chemistry 2016;291 (33):17394-404 [PubMed]
Park Sang Won, Herrema Hilde, Salazar Mario, Cakir Isin, Cabi Serkan, Basibuyuk Sahin Fatma, Chiu Yu-Hsin, Cantley Lewis C, Ozcan Umut BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K Cell metabolism 2014;20 (1):73-84 [PubMed]
Herrema Hilde, Meissner Maxi, van Dijk Theo H., Brufau Gemma, Boverhof Renze, Oosterveer Maaike H., Reijngoud Dirk-Jan, Müller Michael, Stellaard Frans, Groen Albert K., Kuipers Folkert Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor- and Liver X Receptor alpha-Controlled Metabolic Pathways in Mice Hepatology (Baltimore, Md.) 2010;51 (3):806-816 [PubMed]

Prof. MD PhD M. Nieuwdorp (Gutmicrobiota as novel diagnostic and therapeutic targets in cardiometabolism)